Eradication Efficacy of Modified Dual Therapy Compared with Bismuth-Containing Quadruple Therapy as a First-Line Treatment of Helicobacter pylori-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Eradication Efficacy of Modified Dual Therapy Compared with Bismuth-Containing Quadruple Therapy as a First-Line Treatment of Helicobacter pylori

Published:2019-02-25 Issue:3 Volume:114 Page:437-445
ISSN:0002-9270
Container-title:American Journal of Gastroenterology
language:en
Short-container-title:Am J Gastroenterol

Author:

Yang Jing,Zhang Yi,Fan Ling,Zhu Yang-Jie,Wang Ting-Yi,Wang Xing-Wei,Chen Dong-Feng,Lan Chun-Hui

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology,Hepatology

Reference37 articles.

1. Helicobacter pylori infection and antibiotic resistance: A WHO high priority?;Dang;Nat Rev Gastroenterol Hepatol,2017

2. Kyoto global consensus report on Helicobacter pylori gastritis;Sugano;Gut,2015

3. Global burden of cancers attributable to infections in 2012: A synthetic analysis;Plummer;Lancet Glob Health,2016

4. Helicobacter pylori treatment in the era of increasing antibiotic resistance;Graham;Gut,2010

5. A report card to grade Helicobacter pylori therapy;Graham;Helicobacter,2007

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vonoprazan-amoxicillin dual therapy for Helicobacter pylori eradication in Chinese population: A prospective, multicenter, randomized, two-stage study;World Journal of Gastroenterology;2024-07-21

2. An Economic Evaluation of Family‐Based Versus Traditional Helicobacter pylori Screen‐and‐Treat Strategy: Based on Real‐World Data and Microsimulation Model;Helicobacter;2024-07

3. Novel therapeutic regimens against Helicobacter pylori: an updated systematic review;Frontiers in Microbiology;2024-06-07

4. Family‐based Helicobacter pylori infection control and management strategy and screen‐and‐treat strategy are highly cost‐effective in preventing multiple upper gastrointestinal diseases in Chinese population at national level;Helicobacter;2024-05

5. Comparison of the Efficacy of 12-day Concomitant Quadruple Therapy versus 14-day High dose Dual Therapy as a First-line H. pylori Eradication Regimen;The Korean Journal of Gastroenterology;2024-04-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3